116 related articles for article (PubMed ID: 22856387)
21. Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.
Yang Z; Zadjura LM; Marino AM; D'Arienzo CJ; Malinowski J; Gesenberg C; Lin PF; Colonno RJ; Wang T; Kadow JF; Meanwell NA; Hansel SB
J Pharm Sci; 2010 Apr; 99(4):2135-52. PubMed ID: 19780144
[TBL] [Abstract][Full Text] [Related]
22. Nonclinical Pharmacokinetic Evaluation of Desidustat: a Novel Prolyl Hydroxylase Inhibitor for the Treatment of Anemia.
Patel H; Modi N; Chaudhari J; Patel P; Giri P; Patel H; Pandya V; Desai R; Jain M
Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):725-740. PubMed ID: 35881329
[TBL] [Abstract][Full Text] [Related]
23. In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats.
Koudriakova T; Iatsimirskaia E; Tulebaev S; Spetie D; Utkin I; Mullet D; Thompson T; Vouros P; Gerber N
J Pharmacol Exp Ther; 1996 Dec; 279(3):1300-9. PubMed ID: 8968354
[TBL] [Abstract][Full Text] [Related]
24. Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist.
Vachharajani NN; Yeleswaram K; Boulton DW
J Pharm Sci; 2003 Apr; 92(4):760-72. PubMed ID: 12661062
[TBL] [Abstract][Full Text] [Related]
25. Differences in the pharmacokinetics of peroxisome proliferator-activated receptor agonists in genetically obese Zucker and sprague-dawley rats: implications of decreased glucuronidation in obese Zucker rats.
Kim MS; Wang S; Shen Z; Kochansky CJ; Strauss JR; Franklin RB; Vincent SH
Drug Metab Dispos; 2004 Sep; 32(9):909-14. PubMed ID: 15319330
[TBL] [Abstract][Full Text] [Related]
26. The elimination of MTC-220, a novel anti-tumor agent of conjugate of paclitaxel and muramyl dipeptide analogue, in rats.
You F; Hu J; Li X; Li Y
Cancer Chemother Pharmacol; 2013 Jun; 71(6):1453-62. PubMed ID: 23558944
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, brain distribution, and plasma protein binding of the antiepileptic drug lacosamide in rats.
Koo TS; Kim SJ; Ha DJ; Baek M; Moon H
Arch Pharm Res; 2011 Dec; 34(12):2059-64. PubMed ID: 22210031
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of DA-7218, a new oxazolidinone, and its active metabolite, DA-7157, after intravenous and oral administration of DA-7218 and DA-7157 to rats.
Bae SK; Yang SH; Shin KN; Rhee JK; Yoo M; Lee MG
J Pharm Pharmacol; 2007 Jul; 59(7):955-63. PubMed ID: 17637190
[TBL] [Abstract][Full Text] [Related]
30. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
Lee MH; Bae SK; Kim EJ; Kim YG; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695
[TBL] [Abstract][Full Text] [Related]
31. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
Mukai H; Sugimoto T; Ago M; Morino A
Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
[TBL] [Abstract][Full Text] [Related]
33. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of magnolin in rats.
Kim NJ; Song WY; Yoo SD; Oh SR; Lee HK; Lee HS
Arch Pharm Res; 2010 Jun; 33(6):933-8. PubMed ID: 20607499
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of the Absorption, Distribution, Metabolism, and Excretion of Lobeglitazone, a Novel Activator of Peroxisome Proliferator-Activated Receptor Gamma in Rats.
Lee JH; Noh CK; Yim CS; Jeong YS; Ahn SH; Lee W; Kim DD; Chung SJ
J Pharm Sci; 2015 Sep; 104(9):3049-59. PubMed ID: 25648999
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics, oral bioavailability and metabolism of a novel isoquinolinone-based melatonin receptor agonist in rats.
Zhu J; Hu Y; Ho MK; Wong YH
Xenobiotica; 2012 Nov; 42(11):1138-50. PubMed ID: 22642804
[TBL] [Abstract][Full Text] [Related]
37. Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats.
Lee DY; Kim JY; Kim YC; Kwon JW; Kim WB; Lee MG
Biopharm Drug Dispos; 2005 Jul; 26(5):173-82. PubMed ID: 15841492
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and metabolism of 4-O-methylhonokiol in rats.
Yu HE; Oh SJ; Ryu JK; Kang JS; Hong JT; Jung JK; Han SB; Seo SY; Kim YH; Park SK; Kim HM; Lee K
Phytother Res; 2014 Apr; 28(4):568-78. PubMed ID: 23824979
[TBL] [Abstract][Full Text] [Related]
39. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
Colletti AE; Krieter PA
Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
[TBL] [Abstract][Full Text] [Related]
40. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]